calendar
8,421 catalysts · 6,086 phase readout · 2,329 8k filing · 400 earnings · 3 pdufa · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
8,421 catalysts · 6,086 phase readout · 2,329 8k filing · 400 earnings · 3 pdufa · 2 approval · 1 adcom
Sponsor: European Society of Gynaecological Oncology. Phase: . Conditions: D010051, Ovarian Cancer, Advanced-stage Ovarian Cancer, FIGO Stages III and IV, Quality Indicators
Sponsor: Assiut University. Phase: NA. Conditions: Severe Aortic Valve Stenosis
Sponsor: Fudan University. Phase: . Conditions: Adult Refractory Secondary Hemophagocytic Lymphohistiocytosis, Secondary Hemophagocytic Lymphohistiocytosis, HLH
Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Acute Myeloid Leukemia
Sponsor: Grifols Therapeutics LLC. Phase: PHASE3. Conditions: Pulmonary Emphysema in Alpha-1 PI Deficiency
Sponsor: Lahore University of Biological and Applied Sciences. Phase: NA. Conditions: Myofascial Pain Syndrome
Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust. Phase: . Conditions: Asthma, Obstructive Sleep Apnoea (OSA), Dysanapis
Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Total Hip Arthroplasty, Drain Insertion Site
Sponsor: Miltenyi Biomedicine GmbH. Phase: PHASE2. Conditions: Diffuse Large B-cell Lymphoma
Sponsor: Khyber Medical University Peshawar. Phase: PHASE3. Conditions: Major Depressive Disorder, Post-Traumatic Stress Disorder (PTSD)
Sponsor: Qilu Hospital of Shandong University. Phase: NA. Conditions: Type 2 Diabetes Mellitus (T2DM)
Sponsor: Rutgers, The State University of New Jersey. Phase: PHASE2. Conditions: Gastro-Intestinal Cancer
Sponsor: OHSU Knight Cancer Institute. Phase: . Conditions: Acute Leukemia, Lymphoproliferative Disorders, Myeloproliferative Disorders, Myelodysplastic Syndromes
Sponsor: TriCity Research Center. Phase: NA. Conditions: Small Fiber Neuropathy
Sponsor: Biobeat Technologies Ltd.. Phase: NA. Conditions: Blood Pressure, Heart Disease, Hypertension (HTN), Blood Pressure Monitoring
Sponsor: Novelwise Pharmaceutical Corporation. Phase: PHASE1. Conditions: Malignant Neoplasm, Malignant Neoplasm of Brain
Sponsor: Children's Hospital Colorado. Phase: NA. Conditions: Inpatient Pediatric Care, Isolation, Feasibility Studies
Sponsor: University of California, San Francisco. Phase: NA. Conditions: Tobacco Use Disorder, Substance Use Disorder (SUD)
Sponsor: University of Miami. Phase: NA. Conditions: Blood Pressure, Relaxation, Virtual Reality
Sponsor: University of Pittsburgh. Phase: . Conditions: Chronic Pancreatitis, Inflammatory Bowel Diseases, Hepatitis, NASH - Nonalcoholic Steatohepatitis, Acute Pancreatitis, Rheumatoid Arthritis, Diabetes Mellitus, Dyslipidemias, Multiple Sclerosis, Irritable Bowel Syndrome, Chronic Pain, Chronic Disease, Chronic Kidney Diseases, Crohn Disease, Celiac Disease, Biliary Cirrhosis, Bile Acid Synthesis Defect, Gastritis, Cholecystitis, Cholelithiases, IPMN, Cyst Pancreas, Cystic Fibrosis, Pancreatic Exocrine Insufficiency, Diarrhea Chronic, Constipation - Functional, Constipation Chronic Idiopathic
Sponsor: National Institute on Aging (NIA). Phase: . Conditions: Healthy Volunteers, Non-Healthy/Non-Frail, Frail
Sponsor: Region Skane. Phase: . Conditions: Skin Cancer
Sponsor: University of Tennessee. Phase: NA. Conditions: Nutrition, Healthy Diet, Food Preferences
Sponsor: University of Massachusetts, Worcester. Phase: NA. Conditions: Alcohol Use Disorder
Sponsor: Cancer Trials Ireland. Phase: PHASE1. Conditions: Locally Advanced Rectal Cancer
Sponsor: Renmin Hospital of Wuhan University. Phase: . Conditions: Colorectal Adenoma, Artificial Intelligence (AI)
Sponsor: Başakşehir Çam & Sakura City Hospital. Phase: NA. Conditions: Stroke
Sponsor: IU University of Applied Sciences. Phase: NA. Conditions: Healthy Adults, High Altitude, Isolation, Social
Sponsor: Galvanize Therapeutics, Inc.. Phase: . Conditions: Soft Tissue Lesion
Sponsor: Ain Shams University. Phase: . Conditions: Sarcopenia, Fatigue, Orthostatic Intolerance
Sponsor: Suez Canal University. Phase: NA. Conditions: Mandibular Fractures, Symphysis Fractures, Parasymphysis Fractures
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: EARLY_PHASE1. Conditions: Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE), Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD), Progressive Multiple Sclerosis (PMS), Relapsed/Refractory Myasthenia Gravis(r/r MS)
Sponsor: Hong Kong Metropolitan University. Phase: NA. Conditions: Screen Time Exposure
Sponsor: AstraZeneca. Phase: . Conditions: Ovarian Cancer
Sponsor: Scitech Produtos Medicos SA. Phase: NA. Conditions: Venous Stenosis, Venous Occlusion, Chronic Renal Failure
Sponsor: Centre Leon Berard. Phase: PHASE2. Conditions: Localized Resectable Tumor, MSI/dMMR
Sponsor: City of Hope Medical Center. Phase: NA. Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Sponsor: Assiut University. Phase: NA. Conditions: Erectile Dysfunction (ED)
Sponsor: Sadia Ramzan. Phase: NA. Conditions: Disruptive Behaviors
Sponsor: University of Leeds. Phase: NA. Conditions: Parkinson Disease
Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Brain Tumor, Stroke, Ulinastatin, Perioperative Anti-inflammatory Therapy
Sponsor: Yonsei University. Phase: PHASE3. Conditions: Acute Ischemic Stroke
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.. Phase: PHASE3. Conditions: Non-Small Cell Lung Cancer
Sponsor: Novartis Pharmaceuticals. Phase: PHASE2. Conditions: Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
Sponsor: Atlas University. Phase: NA. Conditions: Art Therapy
Sponsor: Wuhan Neurophth Biotechnology Limited Company. Phase: PHASE3. Conditions: Leber Hereditary Optic Neuropathy (LHON)
Sponsor: University of British Columbia. Phase: NA. Conditions: Malnutrition in Children
Sponsor: Shanghai University of Traditional Chinese Medicine. Phase: PHASE2. Conditions: Acute Respiratory Distress Syndrome (ARDS), Acute Lung Injury(ALI), Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano. Phase: PHASE2. Conditions: Inflammation, Smoking Cessation, Diet Modification, Physical Activity, Lung Cancer
Sponsor: Alnylam Pharmaceuticals. Phase: . Conditions: Acute Hepatic Porphyria